Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
Clinical trial NCT00362505 · TERMINATED
Trial details
- NCT number
- NCT00362505
- Sponsor
- Bukwang Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.